Fresenius Medical Care AG & Co. KGaA (FMS), Friday posted third quarter net income attributable to FMC AG & Co. KGaA of $225 million or $0.76 per share, up 9% from $206.34 million or $0.69 per share in the prior year period.
On average, five analysts polled by Thomson Reuters expected the company to earn $0.76 per share. Analysts' estimates typically exclude special items.
Net revenue for the third quarter increased 6.5% to $2.89 billion from $2.71 billion in the previous year period. Street analysts expected revenues of $2.93 billion.
For the nine-month period, net income attributable to FMC AG & Co. KGaA rose to $645 million or $2.16 per share from $603.3 million or $2.03 per share last year. Net revenue for nine months was $8,212 million, up 4% from the same period last year.
Looking forward, for the full year 2009, the company now expects net income attributable to FMC AG & Co. KGaA in the range of $865 million to $890 million. Previously the company expected the net income to be in the range of $850 million and $890 million for the full year 2009.
Revenue is now anticipated to be around $11.2 billion from the prior estimate of $11.1 billion. Street analysts expect earnings of $2.94 per share on revenues of $11.13 billion for the year.
In addition, the company said it expects to spend $550 to $650 million on capital expenditures and $200 to $250 million on acquisitions.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.